Halabi, S., Xie, M., Yu, C., Guo, S., Kim, H., Song, T., Knutson, T., Kobilka, A., Lyman, J., Antonarakis, E. S., Beltran, H., Galsky, M. D., Rosenberg, J. E., Ryan, C. J., Small, E. J., Kelly, W. K., Morris, M. J., Page, D., Dehm, S. M., Armstrong, A. J. (2026). Circulating tumor DNA–based clinical-genetic (CG) prognostic model for radiographic progression-free survival (rPFS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Analysis of Alliance A031201.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5018